Hobden Adrian N

Myriad Genetics Inc.

Pres. Myriad Pharmaceuticals

Avg. Two Year Performance

No Purchase Track Record

29% Avg. Sale Return 14% Compound

Holdings: 234.07K shares

Last Three Months: 26-Aug-24 -- 25-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Diagnostic Substances

Drugs

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions